Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome

Clinical and Developmental Immunology

Volumn 13, Issue 2-4, 2006, Pages 261-264

  Chang, Alice D ^a   Tachdjian, Raffi ^a   Gallagher, Kerry ^a   Mccurdy, Deborah K ^a   Lassman, Charles ^b   Stiehm, E Richard ^a   Yadin, Ora ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiphospholipid syndrome; DiGeorge syndrome; Glomerulonephritis; Homozygous methylene tetrahydrofolate reductase C677T mutations; Mixed cryoglobulinemia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIBODY; ANTISTREPTOLYSIN; AZITHROMYCIN; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CEFOTAXIME; DEOXYRIBONUCLEASE B ANTIBODY; DOUBLE STRANDED DNA; HEMOGLOBIN; HEPARIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RHEUMATOID FACTOR; THROMBOCYTE ANTIBODY; WARFARIN;

ADOLESCENT; ANAMNESIS; ANTIBIOTIC THERAPY; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DIGEORGE SYNDROME; DYSPNEA; FALLOT TETRALOGY; GENE MUTATION; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUNG EMBOLISM; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; PULMONARY ARTERY STENOSIS; PULMONARY VALVE STENOSIS; RECURRENT FEVER; STREPTOCOCCUS INFECTION;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; CRYOGLOBULINEMIA; DIGEORGE SYNDROME; HUMANS; MALE;

EID: 33845633615     PISSN: 17402522     EISSN: 10292357     Source Type: Journal    
DOI: 10.1080/17402520600877778     Document Type: Article

References (23)

1. Beddhu S, Bastacky S, Johnson JP. 2002. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine 81:398-409.
2. Bruno B, Barbier C, Lambilliotte A, Rey C, Turck D. 2002. Autoimmune pancytopenia in a child with DiGeorge syndrome. Eur J Pediatr 161:390-392.
3. Cooper MD, Peterson RDA, Good RA. 1965. A new concept of the cellular basis of immunity. J Pediatr 67:907-908.
4. Davies K, Stiehm ER, Woo P, Murray KJ. 2001. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheum 28:2326-2333.
5. Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. 2003. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol 25:195-197.
6. Etzioni A, Pollack S. 1994. Autoimmune phenomena in DiGeorge syndrome. Isr J Med Sci 30:853.
7. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. 2002. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86:422-425.
8. Hanly JG, Smith SA. 2000. Autoimmune antiphospholipid antibodies and cryoglobulinemia. Lupus 9:264-270.
9. Haywood S, Liesner R, Pindora S, Ganesan V. 2005. Thrombophilia and first arterial ischaemic stroke: A systematic review. Arch Dis Child 90:402-405.
10. Hodson AK, Doughty RA, Norman ME. 1978. Acute encephalopathy, Streptococcal infection, and cryoglobulinemia. Arch Neurol 35:43-44.
11. Jawad AF, McDonald-McGinn DM, Zackai E, Sullivan KE. 2001. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome). J Pediatr 139:715-723.
12. Kratz CP, Niehues T, Lyding S, Heusch A, Janssen G, Gobel U. 2003. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: A case report. Pediatr Hematol Oncol 20:167-172.
13. Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sempowski GD, Rhein ME, Szabolcs P, Hale LP, Buckley RH, Coyne KE, Rice HE, Mahaffey SM, Skinner MA. 2004. Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 113:734-741.
14. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot DE, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306.
15. Nucera C, Vaccaro M, Moleti M, Priolo C, Tortorella G, Angioni A, Ientile R, Violi MA, Loda M, Trimarchi F, Vermiglio F. 2006. Antiphospholipid antibodies syndrome (APS) associated with hyperhomocysteinemia related to MTHFR gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome). J Clin Endocrinol Metab, Epub.
16. Perez E, Sullivan KE. 2002. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pedatr 14:678-683.
17. Pinchas-Hamiel O, Mandel M, Engelberg S, Passwell JH. 1994. Immune hemolytic anemia, thrombocytopenia, and liver disease in a patient with DiGeorge syndrome. Isr J Med Sci 30:530-532.
18. Pong AJH, Cavallo A, Holman GH, Goldman AS. 1985. DiGeorge syndrome: Long-term survival complicated by Graves disease. J Pediatr 106:619-620.
19. Reul GJ, Jr, Cooley DA, Duncan JM, Frazier O, Hallman GL, Livesay JJ, Ott DA, Walker WE. 1985. Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: Analysis of 2680 patients. J Vasc Surg 2:192-204.
20. Schroder AK, Christensen P. 1988. Molecular mimicries between human IgG, IgM rheumatoid factor and Streptococcal IgG Fc receptors. Scand J Rheumatol Suppl 75:199-202.
21. Segni M, Zimmerman D. 2002. Autoimmune hyperthyroidism in two adolescents with DiGeorge/velocardiofacial syndrome (22q11 deletion). Eur J Pediatr 161:233-234.
22. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni P-L. 2006. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65:2-6.
23. Sullivan KE, McDonald-McGinn DM, Driscoll DA, Zmijewski CM, Ellabban AS, Reed L, Emmanuel BS, Zackai EH, Arthreya BH, Keenan G. 1997. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndromes (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum 40:430-436.